Provided by Tiger Trade Technology Pte. Ltd.

Lyra Therapeutics

4.01
+0.28007.51%
Post-market: 4.080.0729+1.82%16:26 EST
Volume:117.91K
Turnover:455.36K
Market Cap:7.12M
PE:-0.14
High:4.32
Open:3.62
Low:3.47
Close:3.73
52wk High:37.50
52wk Low:2.84
Shares:1.77M
Float Shares:1.32M
Volume Ratio:0.46
T/O Rate:8.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-29.4017
EPS(LYR):-71.7474
ROE:-404.48%
ROA:-33.08%
PB:-1.64
PE(LYR):-0.06

Loading ...

Perceptive Advisors LLC Disposes of Lyra Therapeutics Inc. Common Shares

Reuters
·
Nov 14

Lyra Therapeutics Q3 EPS $(3.38) Beats $(5.25) Estimate, Sales $25.000K Miss $195.000K Estimate

Benzinga
·
Nov 13

Lyra Therapeutics Q3 net loss narrows

Reuters
·
Nov 13

Lyra Therapeutics Inc Q3 Net Loss per Share $3.38

THOMSON REUTERS
·
Nov 13

Perceptive Advisors LLC Reports Sale of Lyra Therapeutics Inc. Common Shares

Reuters
·
Nov 11

Lyra Therapeutics Inc expected to post a loss of $5.25 a share - Earnings Preview

Reuters
·
Nov 07

William Blair Keeps Their Hold Rating on Lyra Therapeutics (LYRA)

TIPRANKS
·
Oct 14

Lyra Therapeutics Inc - Enlighten 2 Trial Meets Primary Endpoint in Crs Symptoms

THOMSON REUTERS
·
Oct 06

Lyra Therapeutics Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase 3 ENLIGHTEN 2 Study

GlobeNewswire
·
Oct 06

Lyra Therapeutics Inc. Unveils Presentation on Innovative Sinonasal Drug Implants for Chronic Rhinosinusitis Treatment

Reuters
·
Sep 04

Lyra Therapeutics Receives Nasdaq Deficiency Notice for Failing to Meet Stockholders' Equity Requirement

Reuters
·
Aug 23

U.S. RESEARCH ROUNDUP-ANI Pharmaceuticals, Berkshire Hathaway, Chevron

Reuters
·
Aug 18

Lyra Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 13

Lyra Therapeutics Inc. Unveils Presentation on Innovative Sinonasal Drug Implants for Chronic Rhinosinusitis Treatment

Reuters
·
Aug 13

Lyra Therapeutics Inc - Financing Extends Cash Runway Into 3Q 2026

THOMSON REUTERS
·
Aug 13

Lyra Therapeutics Inc expected to post a loss of $6.02 a share - Earnings Preview

Reuters
·
Aug 08

Lyra Therapeutics Inc - Maria Palasis Appointed Chair of Lyra Board - SEC Filing

THOMSON REUTERS
·
Aug 02

Lyra Therapeutics Inc - Terminates Executive Chairman Harlan Waksal - SEC Filing

THOMSON REUTERS
·
Aug 02

Lyra Therapeutics Appoints Maria Palasis as Chair of the Board Following Departure of Executive Chairman Harlan Waksal

Reuters
·
Aug 02

Lyra Therapeutics Inc. CFO Jason Cavalier Reports Disposal of Common Shares

Reuters
·
Jul 15